欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0683/001
药品名称Lansal 15 mg
活性成分
    • lansoprazole 15.0 mg
剂型Gastro-resistant capsule, hard
上市许可持有人Actavis Group PTC ehf Reykjavikurvegi 76-78 IS-220 Hafnarfjordur Iceland
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Germany (DE)
      Lansoprazol- Actavis 15 mg magensaftresistente Hartkapseln
    • Netherlands (NL)
    • Austria (AT)
      Lansoprazol Actavis 15 mg magensaftresistente Hartkapseln
    • Poland (PL)
    • Latvia (LV)
      Lansoprazol Actavis 15 mg zarnās šķīstošās cietās kapsulas
    • Bulgaria (BG)
    • Czechia (CZ)
      Lansoprazol Actavis 15 mg
    • Slovenia (SI)
许可日期2007/09/04
最近更新日期2015/09/28
药物ATC编码
    • A02BC03 lansoprazole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase